...
首页> 外文期刊>Tumour biology : >Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma
【24h】

Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma

机译:鉴定EWS / NR4A3融合蛋白调控的骨骼外黏液样软骨肉瘤的基因

获取原文
获取原文并翻译 | 示例

摘要

Approximately 75 % of extraskeletal myxoid chondrosarcoma tumors (EMC) harbor a t(9;22) chromosome translocation generating an EWS/NR4A3 fusion protein that is thought to be instrumental in the tumoral process. Current evidence suggests that one function of the fusion protein is to overexpress target genes. We have generated an in vitro human cellular model in which the fusion protein is expressed in mesenchymal bone marrow stem cells. We have performed microarray analyses of these cells and identified several genes overexpressed in the presence of EWS/NR4A3 which are also overexpressed in EMC tumors. These genes and their products represent potential therapeutic targets for EMC tumors.
机译:大约75%的骨骼外黏液样软骨肉瘤肿瘤(EMC)带有t(9; 22)染色体易位,可产生EWS / NR4A3融合蛋白,据认为在肿瘤过程中起重要作用。当前证据表明融合蛋白的功能之一是过表达靶基因。我们已经生成了一种体外人类细胞模型,其中融合蛋白在间充质骨髓干细胞中表达。我们对这些细胞进行了微阵列分析,并鉴定了在EWS / NR4A3存在下过表达的几个基因,这些基因在EMC肿瘤中也过表达。这些基因及其产物代表了EMC肿瘤的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号